Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riitta Tuompo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|November 14, 2013
[Systemic sclerosis]Ritva Peltomaa, Tom Pettersson, Riitta Tuompo, et al.
Rheumatology International|September 18, 2017
Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritisRiitta Tuompo, Timo Hannu, Elisa Huovinen, et al.
BMC Rheumatology|April 11, 2025
Do infections play a role in the development of chronic inflammatory arthritis? A 14-year follow-up study of patients with early arthritisRiitta Tuompo, Timo Hannu, Leena Paimela, et al.
Annals of the Rheumatic Diseases|March 18, 2020
Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic <i>Escherichia coli</i> (DEC)Riitta Tuompo, Tinja Lääveri, Timo Hannu, et al.
BMC Infectious Diseases|December 7, 2013
Cytotoxic response persists in subjects treated for tuberculosis decades agoLaura E Savolainen, Pekka Koskivirta, Anu Kantele, et al.
Rheumatology (Oxford, England)|June 30, 2016
Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register studyJaana T Joensuu, Kalle J Aaltonen, Pasi Aronen, et al.
Clinical Rheumatology|March 3, 2007
Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experienceLiisa Konttinen, Riitta Tuompo, Tea Uusitalo, et al.
Immunity, Inflammation and Disease|November 10, 2021
Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPAJuha-Pekka Kaijasilta, Anne M Kerola, Riitta Tuompo, et al.
Clinical and Vaccine Immunology : CVI|July 5, 2013
Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIVLaura Savolainen, Anu Kantele, Bettina Sandboge, et al.
Seminars in Arthritis and Rheumatism|March 14, 2013
Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based studyKalle J Aaltonen, Liisa M Virkki, Esa Jämsen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|November 14, 2013
[Systemic sclerosis]Ritva Peltomaa, Tom Pettersson, Riitta Tuompo, et al.
Rheumatology International|September 18, 2017
Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritisRiitta Tuompo, Timo Hannu, Elisa Huovinen, et al.
BMC Rheumatology|April 11, 2025
Do infections play a role in the development of chronic inflammatory arthritis? A 14-year follow-up study of patients with early arthritisRiitta Tuompo, Timo Hannu, Leena Paimela, et al.
Annals of the Rheumatic Diseases|March 18, 2020
Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic <i>Escherichia coli</i> (DEC)Riitta Tuompo, Tinja Lääveri, Timo Hannu, et al.
BMC Infectious Diseases|December 7, 2013
Cytotoxic response persists in subjects treated for tuberculosis decades agoLaura E Savolainen, Pekka Koskivirta, Anu Kantele, et al.
Rheumatology (Oxford, England)|June 30, 2016
Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register studyJaana T Joensuu, Kalle J Aaltonen, Pasi Aronen, et al.
Clinical Rheumatology|March 3, 2007
Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experienceLiisa Konttinen, Riitta Tuompo, Tea Uusitalo, et al.
Immunity, Inflammation and Disease|November 10, 2021
Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPAJuha-Pekka Kaijasilta, Anne M Kerola, Riitta Tuompo, et al.
Clinical and Vaccine Immunology : CVI|July 5, 2013
Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIVLaura Savolainen, Anu Kantele, Bettina Sandboge, et al.
Seminars in Arthritis and Rheumatism|March 14, 2013
Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based studyKalle J Aaltonen, Liisa M Virkki, Esa Jämsen, et al.
Pageof 2